{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,15]],"date-time":"2026-02-15T15:11:48Z","timestamp":1771168308097,"version":"3.50.1"},"reference-count":34,"publisher":"Springer Science and Business Media LLC","issue":"12","license":[{"start":{"date-parts":[[2024,8,9]],"date-time":"2024-08-09T00:00:00Z","timestamp":1723161600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,8,9]],"date-time":"2024-08-09T00:00:00Z","timestamp":1723161600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Ann Surg Oncol"],"published-print":{"date-parts":[[2024,11]]},"DOI":"10.1245\/s10434-024-15975-6","type":"journal-article","created":{"date-parts":[[2024,8,9]],"date-time":"2024-08-09T14:03:01Z","timestamp":1723212181000},"page":"8340-8351","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Dynamic Anthropometrics in Pancreatic Cancer: Associations Between Body Composition Changes During Neoadjuvant Therapy and Survival Outcomes After Resection"],"prefix":"10.1245","volume":"31","author":[{"given":"Elliott J.","family":"Yee","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Robert J.","family":"Torphy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Emily K.","family":"Myers","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cheryl","family":"Meguid","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Oskar","family":"Franklin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Toshitaka","family":"Sugawara","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Salvador Rodriguez","family":"Franco","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Toshimasa J.","family":"Clark","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Benedetto","family":"Mungo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Steven A.","family":"Ahrendt","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Richard D.","family":"Schulick","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marco","family":"del Chiaro","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Martin M.","family":"McCarter","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2024,8,9]]},"reference":[{"key":"15975_CR1","doi-asserted-by":"publisher","first-page":"4351","DOI":"10.1245\/s10434-014-3842-z","volume":"21","author":"BA Boone","year":"2014","unstructured":"Boone BA, Steve J, Zenati MS, et al. Serum CA 19\u20139 response to neoadjuvant therapy is associated with outcome in pancreatic adenocarcinoma. Ann Surg Oncol. 2014;21:4351\u20138. https:\/\/doi.org\/10.1245\/s10434-014-3842-z.","journal-title":"Ann Surg Oncol"},{"key":"15975_CR2","doi-asserted-by":"publisher","first-page":"250","DOI":"10.1038\/s41571-023-00734-5","volume":"20","author":"JM Argiles","year":"2023","unstructured":"Argiles JM, Lopez-Soriano FJ, Stemmler B, Busquets S. Cancer-associated cachexia: understanding the tumour macroenvironment and microenvironment to improve management. Nat Rev Clin Oncol. 2023;20:250\u201364. https:\/\/doi.org\/10.1038\/s41571-023-00734-5.","journal-title":"Nat Rev Clin Oncol"},{"key":"15975_CR3","doi-asserted-by":"publisher","first-page":"619","DOI":"10.1002\/jcsm.12528","volume":"11","author":"S Peixoto da Silva","year":"2020","unstructured":"Peixoto da Silva S, Santos JMO, Costa ESMP, Gil da Costa RM, Medeiros R. Cancer cachexia and its pathophysiology: links with sarcopenia, anorexia, and asthenia. J Cachexia Sarcopenia Muscle. 2020;11:619\u201335. https:\/\/doi.org\/10.1002\/jcsm.12528.","journal-title":"J Cachexia Sarcopenia Muscle"},{"key":"15975_CR4","doi-asserted-by":"publisher","first-page":"1623","DOI":"10.1038\/s41416-021-01301-4","volume":"124","author":"M Kordes","year":"2021","unstructured":"Kordes M, Larsson L, Engstrand L, Lohr JM. Pancreatic cancer cachexia: three dimensions of a complex syndrome. Br J Cancer. 2021;124:1623\u201336. https:\/\/doi.org\/10.1038\/s41416-021-01301-4.","journal-title":"Br J Cancer"},{"key":"15975_CR5","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1002\/jcsm.13126","volume":"14","author":"P Fang","year":"2023","unstructured":"Fang P, Zhou J, Xiao X, et al. The prognostic value of sarcopenia in oesophageal cancer: a systematic review and meta-analysis. J Cachexia Sarcopenia Muscle. 2023;14:3\u201316. https:\/\/doi.org\/10.1002\/jcsm.13126.","journal-title":"J Cachexia Sarcopenia Muscle"},{"key":"15975_CR6","doi-asserted-by":"publisher","first-page":"798","DOI":"10.1001\/jamaoncol.2018.0137","volume":"4","author":"BJ Caan","year":"2018","unstructured":"Caan BJ, Cespedes Feliciano EM, Prado CM, et al. Association of muscle and adiposity measured by computed tomography with survival in patients with nonmetastatic breast cancer. JAMA Oncol. 2018;4:798\u2013804. https:\/\/doi.org\/10.1001\/jamaoncol.2018.0137.","journal-title":"JAMA Oncol"},{"key":"15975_CR7","doi-asserted-by":"publisher","first-page":"1188","DOI":"10.12998\/wjcc.v8.i7.1188","volume":"8","author":"O Vergara-Fernandez","year":"2020","unstructured":"Vergara-Fernandez O, Trejo-Avila M, Salgado-Nesme N. Sarcopenia in patients with colorectal cancer: a comprehensive review. World J Clin Cases. 2020;8:1188\u2013202. https:\/\/doi.org\/10.12998\/wjcc.v8.i7.1188.","journal-title":"World J Clin Cases"},{"key":"15975_CR8","doi-asserted-by":"publisher","first-page":"3205","DOI":"10.1007\/s00261-021-03294-3","volume":"47","author":"V Chianca","year":"2022","unstructured":"Chianca V, Albano D, Messina C, et al. Sarcopenia: imaging assessment and clinical application. Abdom Radiol NY. 2022;47:3205\u201316. https:\/\/doi.org\/10.1007\/s00261-021-03294-3.","journal-title":"Abdom Radiol NY"},{"key":"15975_CR9","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2021-053076","volume":"11","author":"JW Wang","year":"2021","unstructured":"Wang JW, Williams M. Exploring definitions of radiological sarcopenia in cancer: a protocol for a scoping review. BMJ Open. 2021;11:e053076. https:\/\/doi.org\/10.1136\/bmjopen-2021-053076.","journal-title":"BMJ Open"},{"key":"15975_CR10","doi-asserted-by":"publisher","first-page":"284","DOI":"10.1016\/j.pan.2016.01.009","volume":"16","author":"JK Onesti","year":"2016","unstructured":"Onesti JK, Wright GP, Kenning SE, et al. Sarcopenia and survival in patients undergoing pancreatic resection. Pancreatology. 2016;16:284\u20139. https:\/\/doi.org\/10.1016\/j.pan.2016.01.009.","journal-title":"Pancreatology"},{"key":"15975_CR11","doi-asserted-by":"publisher","first-page":"1593","DOI":"10.1007\/s11605-015-2835-y","volume":"19","author":"N Amini","year":"2015","unstructured":"Amini N, Spolverato G, Gupta R, et al. Impact total psoas volume on short- and long-term outcomes in patients undergoing curative resection for pancreatic adenocarcinoma: a new tool to assess sarcopenia. J Gastrointest Surg. 2015;19:1593\u2013602. https:\/\/doi.org\/10.1007\/s11605-015-2835-y.","journal-title":"J Gastrointest Surg"},{"key":"15975_CR12","doi-asserted-by":"publisher","first-page":"771","DOI":"10.1002\/jso.23862","volume":"111","author":"S Joglekar","year":"2015","unstructured":"Joglekar S, Asghar A, Mott SL, et al. Sarcopenia is an independent predictor of complications following pancreatectomy for adenocarcinoma. J Surg Oncol. 2015;111:771\u20135. https:\/\/doi.org\/10.1002\/jso.23862.","journal-title":"J Surg Oncol"},{"key":"15975_CR13","doi-asserted-by":"publisher","first-page":"1263","DOI":"10.1001\/jamaoncol.2022.2319","volume":"8","author":"MHG Katz","year":"2022","unstructured":"Katz MHG, Shi Q, Meyers J, et al. Efficacy of Preoperative mFOLFIRINOX vs mFOLFIRINOX plus hypofractionated radiotherapy for borderline resectable adenocarcinoma of the pancreas: the A021501 phase 2 randomized clinical trial. JAMA Oncol. 2022;8:1263\u201370. https:\/\/doi.org\/10.1001\/jamaoncol.2022.2319.","journal-title":"JAMA Oncol"},{"key":"15975_CR14","doi-asserted-by":"publisher","first-page":"2416","DOI":"10.1245\/s10434-014-4285-2","volume":"22","author":"AB Cooper","year":"2015","unstructured":"Cooper AB, Slack R, Fogelman D, et al. Characterization of anthropometric changes that occur during neoadjuvant therapy for potentially resectable pancreatic cancer. Ann Surg Oncol. 2015;22:2416\u201323. https:\/\/doi.org\/10.1245\/s10434-014-4285-2.","journal-title":"Ann Surg Oncol"},{"key":"15975_CR15","doi-asserted-by":"publisher","first-page":"809","DOI":"10.1001\/jamasurg.2018.0979","volume":"153","author":"M Sandini","year":"2018","unstructured":"Sandini M, Patino M, Ferrone CR, et al. Association between changes in body composition and neoadjuvant treatment for pancreatic cancer. JAMA Surg. 2018;153:809\u201315. https:\/\/doi.org\/10.1001\/jamasurg.2018.0979.","journal-title":"JAMA Surg"},{"key":"15975_CR16","doi-asserted-by":"publisher","first-page":"1539","DOI":"10.1200\/JCO.2012.45.2722","volume":"31","author":"L Martin","year":"2013","unstructured":"Martin L, Birdsell L, Macdonald N, et al. Cancer cachexia in the age of obesity: skeletal muscle depletion is a powerful prognostic factor, independent of body mass index. J Clin Oncol. 2013;31:1539\u201347. https:\/\/doi.org\/10.1200\/JCO.2012.45.2722.","journal-title":"J Clin Oncol"},{"key":"15975_CR17","doi-asserted-by":"publisher","first-page":"584","DOI":"10.1016\/j.surg.2016.11.014","volume":"161","author":"C Bassi","year":"2017","unstructured":"Bassi C, Marchegiani G, Dervenis C, et al. The 2016 update of the International Study Group (ISGPS) definition and grading of postoperative pancreatic fistula: 11 years after. Surgery. 2017;161:584\u201391. https:\/\/doi.org\/10.1016\/j.surg.2016.11.014.","journal-title":"Surgery"},{"key":"15975_CR18","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1097\/SLA.0b013e3181b13ca2","volume":"250","author":"PA Clavien","year":"2009","unstructured":"Clavien PA, Barkun J, de Oliveira ML, et al. The Clavien-Dindo classification of surgical complications: five-year experience. Ann Surg. 2009;250:187\u201396. https:\/\/doi.org\/10.1097\/SLA.0b013e3181b13ca2.","journal-title":"Ann Surg"},{"key":"15975_CR19","doi-asserted-by":"publisher","first-page":"2409","DOI":"10.21873\/anticanres.14210","volume":"40","author":"MK Jang","year":"2020","unstructured":"Jang MK, Park C, Hong S, Li H, Rhee E, Doorenbos AZ. Skeletal muscle mass change during chemotherapy: a systematic review and meta-analysis. Anticancer Res. 2020;40:2409\u201318. https:\/\/doi.org\/10.21873\/anticanres.14210.","journal-title":"Anticancer Res"},{"issue":"Suppl 1","key":"15975_CR20","doi-asserted-by":"publisher","first-page":"S28","DOI":"10.1016\/j.afos.2021.03.002","volume":"7","author":"PC Au","year":"2021","unstructured":"Au PC, Li HL, Lee GK, et al. Sarcopenia and mortality in cancer: a meta-analysis. Osteoporos Sarcopenia. 2021;7(Suppl 1):S28-33. https:\/\/doi.org\/10.1016\/j.afos.2021.03.002.","journal-title":"Osteoporos Sarcopenia"},{"key":"15975_CR21","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1186\/s13045-023-01454-0","volume":"16","author":"T Setiawan","year":"2023","unstructured":"Setiawan T, Sari IN, Wijaya YT, et al. Cancer cachexia: molecular mechanisms and treatment strategies. J Hematol Oncol. 2023;16:54. https:\/\/doi.org\/10.1186\/s13045-023-01454-0.","journal-title":"J Hematol Oncol"},{"key":"15975_CR22","doi-asserted-by":"publisher","first-page":"1695","DOI":"10.1002\/cncr.23802","volume":"113","author":"M Ryd\u00e9n","year":"2008","unstructured":"Ryd\u00e9n M, Agustsson T, Laurencikiene J, et al. Lipolysis\u2013not inflammation, cell death, or lipogenesis\u2013is involved in adipose tissue loss in cancer cachexia. Cancer. 2008;113:1695\u2013704. https:\/\/doi.org\/10.1002\/cncr.23802.","journal-title":"Cancer"},{"key":"15975_CR23","doi-asserted-by":"publisher","first-page":"673","DOI":"10.1002\/jcsm.12307","volume":"9","author":"JK Kays","year":"2018","unstructured":"Kays JK, Shahda S, Stanley M, et al. Three cachexia phenotypes and the impact of fat-only loss on survival in FOLFIRINOX therapy for pancreatic cancer. J Cachexia Sarcopenia Muscle. 2018;9:673\u201384. https:\/\/doi.org\/10.1002\/jcsm.12307.","journal-title":"J Cachexia Sarcopenia Muscle"},{"key":"15975_CR24","doi-asserted-by":"publisher","first-page":"2975","DOI":"10.1007\/s00268-015-3205-3","volume":"39","author":"T Akahori","year":"2015","unstructured":"Akahori T, Sho M, Kinoshita S, et al. Prognostic significance of muscle attenuation in pancreatic cancer patients treated with neoadjuvant chemoradiotherapy. World J Surg. 2015;39:2975\u201382. https:\/\/doi.org\/10.1007\/s00268-015-3205-3.","journal-title":"World J Surg"},{"key":"15975_CR25","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1186\/s12885-020-07753-w","volume":"21","author":"IH Kim","year":"2021","unstructured":"Kim IH, Choi MH, Lee IS, Hong TH, Lee MA. Clinical significance of skeletal muscle density and sarcopenia in patients with pancreatic cancer undergoing first-line chemotherapy: a retrospective observational study. BMC Cancer. 2021;21:77. https:\/\/doi.org\/10.1186\/s12885-020-07753-w.","journal-title":"BMC Cancer"},{"key":"15975_CR26","doi-asserted-by":"publisher","first-page":"2458","DOI":"10.1245\/s10434-022-12985-0","volume":"30","author":"S Takaichi","year":"2023","unstructured":"Takaichi S, Tomimaru Y, Kobayashi S, et al. Change impact of body composition during neoadjuvant chemoradiotherapy in patients with resectable and borderline resectable pancreatic ductal adenocarcinoma undergoing pancreatectomy. Ann Surg Oncol. 2023;30:2458\u201368. https:\/\/doi.org\/10.1245\/s10434-022-12985-0.","journal-title":"Ann Surg Oncol"},{"key":"15975_CR27","doi-asserted-by":"publisher","first-page":"527","DOI":"10.1186\/s12967-022-03731-x","volume":"20","author":"I Deichaite","year":"2022","unstructured":"Deichaite I, Sears TJ, Sutton L, et al. Differential regulation of TNFalpha and IL-6 expression contributes to immune evasion in prostate cancer. J Transl Med. 2022;20:527. https:\/\/doi.org\/10.1186\/s12967-022-03731-x.","journal-title":"J Transl Med"},{"key":"15975_CR28","doi-asserted-by":"publisher","first-page":"638","DOI":"10.1016\/j.ijsu.2012.11.007","volume":"10","author":"N Gupta","year":"2012","unstructured":"Gupta N, Goswami B, Mittal P. Effect of standard anthracycline-based neoadjuvant chemotherapy on circulating levels of serum IL-6 in patients of locally advanced carcinoma breast: a prospective study. Int J Surg. 2012;10:638\u201340. https:\/\/doi.org\/10.1016\/j.ijsu.2012.11.007.","journal-title":"Int J Surg"},{"key":"15975_CR29","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1177\/172460080401900207","volume":"19","author":"U Berberoglu","year":"2004","unstructured":"Berberoglu U, Yildirim E, Celen O. Serum levels of tumor necrosis factor alpha correlate with response to neoadjuvant chemotherapy in locally advanced breast cancer. Int J Biol Markers. 2004;19:130\u20134. https:\/\/doi.org\/10.1177\/172460080401900207.","journal-title":"Int J Biol Markers"},{"key":"15975_CR30","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1016\/j.ecl.2020.02.008","volume":"49","author":"KM Gavin","year":"2020","unstructured":"Gavin KM, Bessesen DH. Sex differences in adipose tissue function. Endocrinol Metab Clin North Am. 2020;49:215\u201328. https:\/\/doi.org\/10.1016\/j.ecl.2020.02.008.","journal-title":"Endocrinol Metab Clin North Am"},{"key":"15975_CR31","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1007\/978-3-319-70178-3_2","volume":"1043","author":"MA Bredella","year":"2017","unstructured":"Bredella MA. Sex differences in body composition. Adv Exp Med Biol. 2017;1043:9\u201327. https:\/\/doi.org\/10.1007\/978-3-319-70178-3_2.","journal-title":"Adv Exp Med Biol"},{"key":"15975_CR32","doi-asserted-by":"publisher","first-page":"1243","DOI":"10.1016\/j.pan.2020.07.411","volume":"20","author":"JR Bundred","year":"2020","unstructured":"Bundred JR, Kamarajah SK, Hammond JS, Wilson CH, Prentis J, Pandanaboyana S. Prehabilitation prior to surgery for pancreatic cancer: a systematic review. Pancreatology. 2020;20:1243\u201350. https:\/\/doi.org\/10.1016\/j.pan.2020.07.411.","journal-title":"Pancreatology"},{"key":"15975_CR33","doi-asserted-by":"publisher","first-page":"S183","DOI":"10.1016\/j.pmrj.2016.07.111","volume":"8","author":"A Ngo-Huang","year":"2016","unstructured":"Ngo-Huang A, Parker N, Martinez VA, et al. Poster 68 feasibility of a prehabilitation program for patients with potentially resectable pancreatic cancer: pilot study. PMR. 2016;8:S183. https:\/\/doi.org\/10.1016\/j.pmrj.2016.07.111.","journal-title":"PMR"},{"key":"15975_CR34","doi-asserted-by":"publisher","first-page":"105","DOI":"10.3978\/j.issn.2078-6891.2011.021","volume":"3","author":"UK Ballehaninna","year":"2012","unstructured":"Ballehaninna UK, Chamberlain RS. The clinical utility of serum CA 19\u20139 in the diagnosis, prognosis, and management of pancreatic adenocarcinoma: an evidence based appraisal. J Gastrointest Oncol. 2012;3:105\u201319. https:\/\/doi.org\/10.3978\/j.issn.2078-6891.2011.021.","journal-title":"J Gastrointest Oncol"}],"container-title":["Annals of Surgical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1245\/s10434-024-15975-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1245\/s10434-024-15975-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1245\/s10434-024-15975-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,10,10]],"date-time":"2024-10-10T14:08:58Z","timestamp":1728569338000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1245\/s10434-024-15975-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,8,9]]},"references-count":34,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2024,11]]}},"alternative-id":["15975"],"URL":"https:\/\/doi.org\/10.1245\/s10434-024-15975-6","relation":{},"ISSN":["1068-9265","1534-4681"],"issn-type":[{"value":"1068-9265","type":"print"},{"value":"1534-4681","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,8,9]]},"assertion":[{"value":"22 March 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 July 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 August 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Dr. Del Chiaro has received an industry grant (Haemonetics, Inc) to conduct a multicenter study. Dr. Del Chiaro is the principal investigator of an international multicenter study sponsored by Boston Scientific.\u00a0Dr. Schulick is a coinventor of a patent licensed to DynamiCure (managed by the University of Colorado) outside the submitted work. The remaining authors have no conflicts of interest.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Disclosure"}}]}}